PAS
XERS icon

Point72 Asia (Singapore)’s Xeris Biopharma Holdings XERS Stock Holding History

Point72 Asia (Singapore)’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6,300
Closed -$29.4K – 1284
2025
Q2 		$29.4K Sell
6,300
-20,968
-77% -$96.1K 0.01% 686
2025
Q1 		$150K Buy
+27,268
New +$110K 0.04% 328

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Point72 Asia (Singapore)'s XERS Position: Q3 2025 in Review

Point72 Asia (Singapore) sold out of Xeris Biopharma Holdings (XERS) in Q3 2025, closing a stake of 6,300 shares — an estimated $29.4K sold.

Point72 Asia (Singapore) first reported a position in XERS in Q1 2025 and held it in 2 quarters. The position peaked at $150K in Q1 2025. 230 funds tracked by Wall St. Rank hold XERS as of Q3 2025.

  • Point72 Asia (Singapore) reported no remaining Xeris Biopharma Holdings position as of Q3 2025 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 6,300 Xeris Biopharma Holdings shares in Q3 2025, an estimated $29.4K.
  • Point72 Asia (Singapore) first reported a position in Xeris Biopharma Holdings in Q1 2025 and held it in 2 quarters.
  • Point72 Asia (Singapore)'s Xeris Biopharma Holdings position peaked at $150K in Q1 2025.
  • 230 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.